On March 11, PEPDOO (EYOSON GROUP) and Jiangnan University held a grand signing ceremony for their strategic partnership and the inauguration of the Synthetic Biology Joint Research Institute at Jiangnan University. The event was attended by key representatives from government, academia, and industry, including Kong Shuguang, Secretary of the Party Leadership Group and Director of the Xiamen Science and Technology Bureau, Professor Wu Zhengguo, Party Secretary of Jiangnan University, and Chairman Huang of PEPDOO (EYOSON GROUP). This collaboration, centered on synthetic biology, integrates the scientific research strengths of the university with the industrial expertise of a leading enterprise, marking a new phase in China’s coordinated "industry-university-research-application" development and injecting strong momentum into the high-quality growth of the bioeconomy.
Synthetic Biology: A Revolutionary Force in Biotechnology
Synthetic biology, an emerging interdisciplinary field combining modern biology with multiple scientific systems, represents the third biotechnology revolution following the discovery of the DNA double helix structure and the Human Genome Project. Characterized by the engineering-based design and synthesis of genomes, synthetic biology serves as a key driver of new productivity in biomanufacturing. It is transforming our understanding of life and demonstrating immense potential across various sectors, including pharmaceuticals, food, energy, environment, and agriculture.
▲Professor Wu Zhengguo, Secretary of the Party Committee of Jiangnan University, delivered a speech
▲PEPDOO(EYOSON GROUP) Chairman Mr. Huang delivered a speech
Government-Academia-Industry Collaboration: Fertile Ground for Innovation
During the ceremony, Professor Wu Zhengguo highlighted the innovative "Enterprise Proposes Problems – Universities Provide Solutions – Market Validates Outcomes" closed-loop mechanism, ensuring synergy between scientific innovation and industrial development. Chairman Huang, using the metaphor of "bidirectional gene recombination," emphasized that PEPDOO (EYOSON GROUP) has long prioritized synthetic biology research, with significant advancements in enzyme preparations, recombinant proteins, and small functional molecules. This collaboration with Professor Liu Liming’s team at Jiangnan University will focus on biomanufacturing, driving technological innovation and industrial upgrades in small molecule biosynthesis while breaking foreign technological barriers and securing a leading position in the field of biosynthesis.
▲ Dr. Yu Tian (first from right) and Professor Liu Liming of Jiangnan University signed the contract
▲General Manager Xu Mei (first from right) and Professor Liu Liming of Jiangnan University jointly unveiled the plaque
Signing and Inauguration: Defining Clear Roles in Innovation
In the presence of key stakeholders, Dr. Yu Tian, Director of the Group’s Microbial Innovation Research Institute, and Professor Liu Liming completed the contract exchange. Simultaneously, General Manager Xu Mei and Professor Liu Liming jointly unveiled the Synthetic Biology Joint Research Institute. These actions reflect the well-defined roles of government, academia, and industry: the government fosters an innovation ecosystem, universities provide cutting-edge technologies, and enterprises drive industrial applications. Together, they establish a full-cycle development framework that ensures foundational research, pilot-scale transformation, and large-scale production.
University-Enterprise Synergy: Strengthening the Foundation of Innovation
Jiangnan University, a premier institution in food science and bioengineering, is regarded as a training ground for synthetic biology experts in China. The university has made remarkable progress in synthetic biology, with Professor Liu Liming’s team achieving significant breakthroughs in high-yield strain selection, microbial cell factory engineering, and biocatalysis for pharmaceuticals and chemicals. Meanwhile, PEPDOO (EYOSON GROUP), a national high-tech enterprise dedicated to microbial innovation, probiotic solutions, novel enzyme preparations, and synthetic biology, possesses a fully integrated industrial chain covering strain cultivation, fermentation processes, and functional validation. Their prior collaboration on precision peptide synthesis has already filled a market gap in China, demonstrating the effectiveness of the "university R&D + enterprise commercialization" model.
This upgraded partnership will focus on high-value products such as anti-aging functional ingredients and novel enzyme preparations. Through the joint research institute, the collaboration aims to achieve three major breakthroughs: tackling critical biomanufacturing challenges, developing a bio-based green product portfolio, and fostering interdisciplinary industry-academia talent, supporting Xiamen’s vision to become a bioeconomy demonstration zone.
Government Support: Fostering a Thriving Innovation Ecosystem
The Xiamen Science and Technology Bureau plays a crucial role in facilitating this collaboration by providing comprehensive support in project coordination and policy incentives. By leveraging Jiangnan University’s research capabilities, PEPDOO (EYOSON GROUP)’s industrial expertise, and the government’s ability to construct an enabling ecosystem, a multi-layered innovation network is taking shape—spanning fundamental research, pilot-scale production, and industrial clusters. This initiative strengthens PEPDOO (EYOSON GROUP)’s leadership in synthetic biology within the biotech sector while enhancing Xiamen’s biotechnology ecosystem and contributing to the formation of a regionally competitive industrial cluster.
▲Kong Shuguang, Party Secretary and Director of Xiamen Science and Technology Bureau, delivered a speech
Commitment to Microbial Innovation and Global Health
With 15 years of deep expertise in biotechnology, PEPDOO (EYOSON GROUP) remains committed to its vision of becoming a global leader in microbial innovation solutions. The establishment of the Synthetic Biology Joint Research Institute further solidifies an innovation-driven growth path—anchored in synthetic biology, fueled by green manufacturing, and dedicated to the health industry. Moving forward, PEPDOO (EYOSON GROUP) will leverage the research institute as an innovation hub, collaborating with global partners to propel the high-quality development of the health industry, ensuring a healthier future for humanity through technological advancements. The journey of strategic collaboration has begun, and the tree of synthetic biology is flourishing.
